Logo Image
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsPeer ExchangeInsightsCase StudiesCase of the QuarterClinical ForumsPractice OwnershipRapid ReadoutShortsVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Priya Patel, OD

Advertisement

Articles by Priya Patel, OD

contact lenses closeup

Engineer a specialty contact lens practice

BySusan A. Resnick OD, FAAO, FSLS,Priya Patel, OD
May 11th 2020

Contact lens experts detail how to help more patients see better and deliver life-altering care.

Figure 1. Topography of the keratoconic patient in Case 1.

9 simple solutions to 9 complex cases

ByPriya Patel, OD,Caryn Nearnberg, OD,Susan Resnick, OD, FAAO, FSLS
July 8th 2019
Advertisement

Latest Updated Articles

  • Figure 1. Topography of the keratoconic patient in Case 1.
    9 simple solutions to 9 complex cases

    July 8th 2019

  • contact lenses closeup
    Engineer a specialty contact lens practice

    May 11th 2020



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours

2

FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia

3

Duravyu for wet AMD misses primary end point in phase 3 LUCIA trial

4

FDA approves subcutaneous Enspryng for TED

5

Missed AAOpt 2026? Here are the highlights by specialty

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us